MARSICO CAPITAL MANAGEMENT LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSICO CAPITAL MANAGEMENT LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$1,290,000
+25.4%
13,255
+58.1%
0.04%
+12.5%
Q2 2020$1,029,000
+32.6%
8,386
-5.3%
0.03%
-3.0%
Q1 2020$776,000
-56.3%
8,857
-47.9%
0.03%
-47.6%
Q4 2019$1,777,000
-75.3%
16,991
-72.8%
0.06%
-77.5%
Q3 2019$7,194,000
-31.6%
62,537
+2.5%
0.28%
-25.3%
Q2 2019$10,514,000
-15.7%
60,990
-17.5%
0.38%
-16.7%
Q1 2019$12,468,000
+72.5%
73,961
-0.3%
0.45%
+47.5%
Q4 2018$7,228,000
-54.6%
74,219
-19.5%
0.30%
-43.3%
Q3 2018$15,924,000
+983.3%
92,187
+473.2%
0.54%
+3486.7%
Q3 2015$1,470,00016,0830.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders